Larimar Therapeutics LRMR
NASDAQ LRMR
$3.15 +0.01 (+0.48%)
As of: Sep 30, 2026 · 1:51 PM EDT

Larimar Therapeutics, Inc. (LRMR) Accounts Payables (2013 - 2026)

Updated

Larimar Therapeutics' Accounts Payables came in at $7.6 million for Q2 2026, up 82.2% from $4.17 million a year earlier.

Analysis

Larimar Therapeutics, Inc. (LRMR) Accounts Payables (2013 - 2026) Analysis & Trends

At the end of FY2025, Larimar Therapeutics' Accounts Payables was $5.22 million, up 115.2% from FY2024.

  • Accounts Payables carries a five-year compound annual growth rate of 14.6% (FY2020 to FY2025).
  • Going back by year, Accounts Payables was $2.42 million in FY2024 (+88.9%), $1.28 million in FY2023 (-23.9%), $1.69 million in FY2022 (+1.6%) and $1.66 million in FY2021 (-37.0%).
  • The five-year range for quarterly Accounts Payables is $425,000 (Q2 2022) to $11.1 million (Q3 2025).
  • The fastest year-over-year change in Accounts Payables over five years came in Q3 2025 (growth of 558.4%), and the weakest in Q1 2023 (a decline of 71.2%).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.60 Mn
Dec 31, 2025 5.22 Mn
Sep 30, 2025 11.10 Mn
Jun 30, 2025 4.17 Mn
Mar 31, 2025 2.27 Mn
Dec 31, 2024 2.42 Mn
Sep 30, 2024 1.69 Mn
Jun 30, 2024 2.92 Mn
Mar 31, 2024 1.92 Mn
Dec 31, 2023 1.28 Mn
Sep 30, 2023 756,000.00
Jun 30, 2023 2.34 Mn
Mar 31, 2023 695,000.00
Dec 31, 2022 1.69 Mn
Sep 30, 2022 849,000.00
Jun 30, 2022 425,000.00
Mar 31, 2022 2.42 Mn
Dec 31, 2021 1.66 Mn
Sep 30, 2021 1.77 Mn
Jun 30, 2021 1.46 Mn
API Access

Larimar Therapeutics, Inc. Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=LRMR&period=max&api_key=YOUR_API_KEY